TickerFacts.

UroGen Pharma Ltd. (URGN) — Revenue

Annual figures by period end, from SEC filings.

2017-12-31: $8.16M2018-12-31: $1.13M2019-12-31: $18.0K2020-12-31: $11.80M2021-12-31: $48.04M2022-12-31: $64.36M2023-12-31: $82.71M2024-12-31: $90.40M2025-12-31: $109.79M$109.79M
2017-12-31Revenue (USD)2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$109.79M+21.4%2026-03-02From 2025-01-01
2024-12-31$90.40M+9.3%2026-03-02From 2024-01-01
2023-12-31$82.71M+28.5%2025-03-10From 2023-01-01
2022-12-31$64.36M+34.0%2024-03-14From 2022-01-01
2021-12-31$48.04M+307.2%2023-03-24From 2021-01-01
2020-12-31$11.80M+65450.0%2022-03-21From 2020-01-01
2019-12-31$18.0K-98.4%2021-03-18From 2019-01-01
2018-12-31$1.13M-86.2%2020-03-02From 2018-01-01
2017-12-31$8.16M—2020-03-02From 2017-01-01